Strong 2025 Performance, Pascal Soriot Highlights Continued Growth – AstraZeneca
AstraZeneca/LinkedIn

Strong 2025 Performance, Pascal Soriot Highlights Continued Growth – AstraZeneca

AstraZeneca shared a post on LinkedIn:

News for Investors and Media
Our CEO Pascal Soriot shares our strong 2025 performance with continued growth and exceptional pipeline delivery across all therapy areas and major regions.

This momentum reflects the great work of our teams to deliver for people, society and the planet. Learn more.”

Other articles featuring AstraZeneca on OncoDaily.